ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business trends

COVID a mixed bag for Japan's medical and sanitary goods companies

Test kit makers see sales jump while pharmaceuticals struggle

TOKYO -- The yearlong COVID-19 pandemic presented a mixed picture for medical and sanitary goods makers in Japan, as earnings results from companies such as Unicharm, Takara Bio and big drugmakers revealed last week.

Unicharm, best known for its diapers, on Friday announced a 1% decline in sales for the January to March quarter, while its net profit rose 4.6% from the previous year. The company is a major manufacturer of masks and wipes -- goods in high demand for the fight against infection. Unicharm forecasts a net profit of 75 billion yen ($690 million) in 2021, up 43% on the year.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more